<DOC>
	<DOCNO>NCT02050958</DOCNO>
	<brief_summary>Oxford Pharmascience ( sponsor ) develop new formulation Ibuprofen ( OXP001 - study drug ) propose less side effect currently report standard prescription strength Ibuprofen . This study compare study drug already market formulation prescription strength Ibuprofen ( reference product ) look drug take body also perform specialist procedure call endoscopy ( specifically gastroscopy ) . The safety tolerability study drug also assess . The study involve approximately 44 healthy male female subject . Subjects randomly assign receive either study drug reference product 8 day . On Day 1 , subject receive single 800 mg dose ibuprofen . On Days 2 9 , subject receive 800 mg ibuprofen three time day .</brief_summary>
	<brief_title>Pilot Study OXP001 Brufen Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Healthy subject Aged 1855 year Normal , healthy upper gastrointestinal tract History concurrent gastric irritation ulcer History allergy nonsteroidal antiinflammatory drug ( NSAIDs )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>